Israeli Medical Advances to Showcase at BioMed 2012
Error: Contact form not found.
by JNS.org
Tel Aviv will be hosting the BioMed 2012 conference May 21-23 to display advancements in the biotechnology industry, including in stem-cell research. Sixty Israeli medical device and biopharmaceutical companies will present at the conference to about 6,000 visitors, reported the Times of Israel.
Israel has made notable advancements in the biopharmaceutical and stem cell research industries. Recently, Hadassah Ein Kerem Hospital doctors succeeded in significantly increasing the number of red blood cells in a 7-year-old girl suffering from aplastic bone marrow. The disease was impeding her body from manufacturing new red blood cells.
Also recently, the U.S. Food and Drug Administration (FDA) approved a drug developed by Israel’s Protalix to treat Gaucher’s disease.
Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says










